Skip to main content
. 2023 Oct 19;141(11):1052–1061. doi: 10.1001/jamaophthalmol.2023.4659

Table. Characteristics of Data Sets 1, 2, and 3.

Characteristic Data set 1 Data set 2 Data set 3
Role in model development Training, cross validation External validation External validation
Setting of data collection Clinical study Routine patient care Routine patient care
Location of acquisition Atlanta, Georgia; Portland, Oregon; Bethesda, Maryland; Durham, North Carolina Durham, South Durham, Raleigh, North Carolina Morrisville, Cary, North Carolina
SD-OCT device Bioptigen SD-OCT Heidelberg spectralis Heidelberg spectralis
No. of patients 316 53 48
No. of eyes 316 53 48
No. of OCT volumes 1085 53 48
iAMD to iAMD, No. (%) 721 (66.5) 30 (56.6) 22 (45.8)
iAMD to GA, No. (%) 60 (5.5) 23 (43.4) 26 (54.2)
GA to GA, No. (%) 304 (28.0) 0 0
Data labeling Grading in certified reading center Consensus grading by 3 ophthalmologists Consensus grading by 3 ophthalmologists
Demographic characteristics
Age, mean (SD), y 74 (8) 83 (8) 81 (8)
Sex, No. (%)
Female 185 (59) 32 (60) 32 (67)
Male 131 (41) 16 (33) 21 (40)
Race and ethnicity, No. (%)a
Asian 3 (1) 1 (2) 0
Black 5 (2) 1 (2) 2 (4)
Hispanic/Latino NA 0 0
Non-Hispanic/Latino NA 50 (94) 47 (98)
White 298 (95) 50 (94) 46 (96)
Other/unknowna 10 (3) 1 (2) 0
Declined to answer NA 3 (6) 1 (2)

Abbreviations: GA, geographic atrophy; iAMD, intermediate age-related macular degeneration; NA, not applicable; OCT, optical coherence tomography; SD-OCT, spectral-domain optical coherence tomography.

a

Race and ethnicity data were acquired via patient self-reported data as reflected in the electronic medical record. As such, the category of other reflects the record and cannot be further defined herein.